603235 天新藥業
按盤價 
26.910 +0.270 (+1.014%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 11.381 | 11.479 | 20.853 | 48.563 | 71.640 |
| 總資產報酬率 ROA (%) | 9.544 | 9.741 | 16.302 | 25.383 | 31.792 |
| 投入資產回報率 ROIC (%) | 11.040 | 11.245 | 19.443 | 38.667 | 55.291 | 邊際利潤分析 |
| 銷售毛利率 (%) | 42.266 | 38.272 | 37.225 | 43.251 | 54.280 |
| 營業利潤率 (%) | 36.425 | 29.874 | 31.486 | 34.759 | 45.735 |
| 息稅前利潤/營業總收入 (%) | 30.940 | 24.588 | 27.560 | 36.061 | 49.231 |
| 淨利潤/營業總收入 (%) | 30.645 | 25.285 | 26.992 | 29.491 | 38.509 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 94.957 | 92.313 | 91.246 | 95.355 | 91.735 |
| 價值變動淨收益/利潤總額(%) | 0.624 | 0.367 | 1.511 | -0.757 | 0.805 |
| 營業外收支淨額/利潤總額(%) | -0.471 | 0.522 | 0.009 | -0.390 | -0.651 | 償債能力分析 |
| 流動比率 (X) | 7.821 | 6.766 | 10.175 | 2.333 | 1.105 |
| 速動比率 (X) | 6.394 | 5.728 | 8.663 | 1.734 | 0.883 |
| 資產負債率 (%) | 15.471 | 16.841 | 13.290 | 35.348 | 60.299 |
| 帶息債務/全部投入資本 (%) | -5.267 | -5.832 | -6.832 | 2.632 | 10.286 |
| 股東權益/帶息債務 (%) | -1,845.608 | -1,659.567 | -1,452.416 | 3,139.465 | 730.187 |
| 股東權益/負債合計 (%) | 546.356 | 493.804 | 652.428 | 182.901 | 65.840 |
| 利息保障倍數 (X) | -5.823 | -4.518 | -7.013 | 25.091 | 12.984 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 37.849 | 46.593 | 46.227 | 38.788 | 34.454 |
| 存貨周轉天數 (天) | 141.024 | 147.134 | 109.004 | 92.540 | 102.118 |
| 備註： | 即時報價更新時間為 02/12/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
